Clinical Trial Update: Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing pamidronate to zoledronic acid for preventing transplant-related bone loss in heart-lung and lung transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart-lung Transplant Complications
• Lung Transplant Complications
• Osteopenia

Drugs mentioned

• Aredia (pamidronate disodium)
• Zometa (Zoledronic acid)

Snippet

Sponsor: Bayside Health | Conditions: Osteopenia, Complications of Heart-lung Transplant | Phase 4 | Status: COMPLETED